Results 161 to 170 of about 1,307,128 (249)
El apoyo de España a la Gobernanza Democrática en América Latina
Marisa Ramos
openalex +1 more source
Objective Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore ...
Jihyun Na +4 more
wiley +1 more source
Eliminating the AI digital divide by building local capacity. [PDF]
Gulamali F +46 more
europepmc +1 more source
ENTRE LA LEGITIMIDAD Y LA EFICACIA: REFORMAS EN LOS SISTEMAS DE ELECCIÓN PRESIDENCIAL EN AMÉRICA LATINA [PDF]
Daniel Buquet
openalex
Objective We assessed whether shared decision‐making (SDM) and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE) differs by PtDA setting, modality, and the viewing experience. Methods Patients with SLE were invited to view a self‐administered
Jasvinder A. Singh +20 more
wiley +1 more source
Ornamental Vascular Plant Diversity in Basilicata (Southern Italy). [PDF]
Di Gristina E +4 more
europepmc +1 more source
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Gross primary productivity analyses suggest higher ENSO-mediated impacts in lowland cacao areas compared to mountain coffee regions in Latin America. [PDF]
González-González A +3 more
europepmc +1 more source
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang +4 more
wiley +1 more source

